Media  Kit

For Media Inquiries, please contact:

Christine Lindenboom
VP, Investor Relations & Corporate Communications
media@alnylam.com

 

Fact Sheets

  • Alnylam Corporate Overview (PDF)
  • RNA Interference (RNAi) and the Future of Drug Development (U.S. Version) (PDF)
  • Hereditary ATTR Amyloidosis (hATTR amyloidosis) Backgrounder (PDF)
  • APOLLO Phase 3 Clinical Trial Overview (U.S. Version) (PDF)
  • Acute Hepatic Porphyrias (AHPs) Backgrounder (PDF)
  • ENVISION Phase 3 Clinical Trial Overview (PDF)
  • Givosiran Backgrounder (PDF)
  • ONPATTROTM (patisiran) Product Fact Sheet (U.S. Version) (PDF)

 

Photos

Executive Officers

 

Illustrations

 

Logos

SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.